We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REBN:NASDAQReborn Coffee, Inc. Analysis

Data as of 2026-07-10 - not real-time

$1.46

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Reborn Coffee’s stock is trading at $1.46, well below its 20‑day SMA of 1.53 and 50‑day SMA of 1.87, indicating a sustained bearish bias. The RSI sits at 39.6, flirting with oversold territory but not yet signaling a clear reversal, while the MACD line has crossed above its signal line, offering a modest bullish hint that is outweighed by the overall downtrend and decreasing volume. Fundamentally, the company is in distress: operating margins are negative, cash flow is deeply negative, and the debt‑to‑equity ratio exceeds 200%, creating a precarious balance sheet. Recent material news announced a new CEO with a strong operational track record and a strategic push toward blockchain‑enabled financial management, which could improve execution but remains unproven. The stock’s beta of 1.88 and 30‑day volatility of over 87% amplify price swings, while the market cap under $13 million and thin trading volume raise liquidity concerns. In this context, the equity appears overvalued relative to its book value (P/B ≈ 4) and offers no dividend, making it a high‑risk speculative play despite the potential upside from leadership changes.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below key moving averages
  • Bearish trend with decreasing volume
  • Weak balance sheet and negative cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • New CEO may improve operational execution
  • Blockchain initiative could create strategic advantage
  • Continued financial strain and high debt load

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential turnaround if leadership delivers
  • Sector cyclical exposure may limit upside
  • Persistent liquidity and solvency challenges

Key Metrics & Analysis

Financial Health

Revenue Growth207.80%
Profit Margin-75.59%
ROE-430.44%
ROA-27.96%
Debt/Equity221.40
P/B Ratio4.0
Op. Cash Flow$-6607782
Free Cash Flow$-9396794

Technical Analysis

TrendBearish
RSI39.6
Support$1.38
Resistance$1.97
MA 20$1.53
MA 50$1.87
MA 200$1.92
MACDBullish
VolumeDecreasing
Fear & Greed Index94.59

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta1.88
Volatility87.15%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.